← Eichor
Condition: Immunocompromised Patients Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Immunocompromised Patients

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Cytomegalovirus Reactivation in ICU Patients Requiring Prolong Mechanical Ventilation
Phase N/A · 1 location(s) · Sanjay Gandhi Postgraduate Institute of Medical Sciences · NCT06520605Adoptive T Lymphocyte Administration for Chronic Norovirus Treatment in Immunocompromised Hosts
Phase 1 · 3 location(s) · Children's National Research Institute · NCT04691622A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
Phase 3 · 148 location(s) · Pfizer · NCT07013474Third Party Viral Specific T-cells (VSTs)
Phase 2 · 4 location(s) · Children's Hospital Medical Center, Cincinnati · NCT02532452Natural History, Epidemiology and Pathogenesis of Severe HPV-Related Diseases (Neptune)
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT05026138Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous SCC for Immunocompromised Patients
NA · 11 location(s) · Alpha Tau Medical LTD. · NCT06615635OPtimisation of Antiviral Therapy in Immunocompromised COVID-19 Patients: a Randomized Factorial Controlled Strategy Tri
Phase 2 · 18 location(s) · ANRS, Emerging Infectious Diseases · NCT05587894Cologne Cohort of Neutropenic Patients (CoCoNut)
Phase N/A · 1 location(s) · University Hospital of Cologne · NCT01821456Baloxavir and Oseltamivir for the Treatment of Severe Influenza Infection in Immunocompromised Patients
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT04712539Immunogenicity of RSVPreF3 Vaccine in Immunocompromised Persons
Phase 2 · 1 location(s) · Johns Hopkins University · NCT07050732Immunogenicity, Efficacy and Safety of Recombinant Herpes Zoster Vaccine in Frail Patients
Phase N/A · 1 location(s) · Fondazione IRCCS Policlinico San Matteo di Pavia · NCT07321808Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Phase 1 · 1 location(s) · M.D. Anderson Cancer Center · NCT03425526Study Assessing the Feasibility, Safety and Efficacy of Genetically Engineered Glucocorticoid Receptor Knock Out Virus S
Phase 1 · 1 location(s) · M.D. Anderson Cancer Center · NCT05101213Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
Phase 3 · 28 location(s) · Ansun Biopharma, Inc. · NCT03808922Clinical Study on Immunogenicity and Safety of Lyophilized Vero Cell-Derived Human Rabies Vaccine in Special Populations
Phase N/A · 1 location(s) · Liaoning Chengda Biotechnology CO., LTD · NCT07120464Chronic Pulmonary Aspergillosis and Ambisome Aerosol with Itraconazole
Phase 3 · 1 location(s) · Poitiers University Hospital · NCT03656081Analysis of the Specificity and Persistence of Nasal Immune Responses to Respiratory Viral Antigens in Immunocompromised
Phase N/A · 1 location(s) · Fondazione IRCCS Policlinico San Matteo di Pavia · NCT07295535Remdesivir for the Treatment of Upper Respiratory Tract Infection Due to RSV in Immunocompromised Individuals
Phase 2 · 3 location(s) · Fred Hutchinson Cancer Center · NCT06817889OPtimisation of Antiviral Therapy in Immunocompromised COVID-19 Patients
Phase 2 · 4 location(s) · Calmy Alexandra · NCT07406217Expansion of Virus-Specific Lymphocytes for Cell Therapy
Phase 1 · 1 location(s) · Hospital Israelita Albert Einstein · NCT06011486Treatment With Amivantamab and Hyaluronidase or Cetuximab for Advanced Skin Cancer in People With a Weakened Immune Syst
Phase 2 · 38 location(s) · National Cancer Institute (NCI) · NCT07042295Remote Temperature Monitoring of Patients At Risk for Developing Fever
NA · 1 location(s) · AION Biosystems · NCT06752512Vaccine-induced Immunity in Immunocompromised Patients
Phase N/A · 1 location(s) · University of Cologne · NCT06612515Viral Infections in Healthy and Immunocompromised Hosts
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT01306084ItAlian ReGistry Of pNeumoniA in immUnocompromised paTients (ARGONAUT)
Phase N/A · 1 location(s) · Societa Italiana di Pneumologia · NCT06755814Personalized Immunological Score for the Prediction of Severe Infectious Events in Immunocompromised Patients and Tailor
Phase N/A · 1 location(s) · Fondazione IRCCS Policlinico San Matteo di Pavia · NCT07379554Immunosuppression and Intensive Care Unit-acquired Multidrug-resistant Bacteria
Phase N/A · 1 location(s) · University Hospital, Lille · NCT06652126Study of Antivascular Therapy Combined With Chemotherapy Versus Chemotherapy in Adjuvant Therapy of TNBC-BLIS Patients (
Phase 3 · 15 location(s) · Fudan University · NCT05909332The Effect of Echinacea (Immulant ®) in the Treatment of CRYPTOSPORIDIOSIS in Immunocompromised Children
Phase 2 · 1 location(s) · Al-Azhar University · NCT07388615BioMArkeRs of INflammation, Infection, and Immunity in the Critical Area (MARINA): the Use of Inflammatory and Immunity
Phase N/A · 1 location(s) · University of Turin, Italy · NCT07682766
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.